| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA491508
Max Phase: Preclinical
Molecular Formula: C30H33ClN4O
Molecular Weight: 464.61
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CN(CCC(=O)N1CCN(c2ccccc2C#N)CC1)CCC1c2ccccc2-c2ccccc21.Cl
Standard InChI: InChI=1S/C30H32N4O.ClH/c1-32(16-14-28-26-11-5-3-9-24(26)25-10-4-6-12-27(25)28)17-15-30(35)34-20-18-33(19-21-34)29-13-7-2-8-23(29)22-31;/h2-13,28H,14-21H2,1H3;1H
Standard InChI Key: LGFUASMNACVYKA-UHFFFAOYSA-N
Associated Targets(non-human)
Somatostatin receptor 1 154 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 464.61 | Molecular Weight (Monoisotopic): 464.2576 | AlogP: 4.73 | #Rotatable Bonds: 7 |
| Polar Surface Area: 50.58 | Molecular Species: BASE | HBA: 4 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 9.54 | CX LogP: 4.69 | CX LogD: 2.57 |
| Aromatic Rings: 3 | Heavy Atoms: 35 | QED Weighted: 0.51 | Np Likeness Score: -1.12 |
References
| 1. Troxler T, Hurth K, Mattes H, Prashad M, Schoeffter P, Langenegger D, Enz A, Hoyer D.. (2009) Discovery of novel non-peptidic beta-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists., 19 (5): [PMID:19208473] [10.1016/j.bmcl.2009.01.072] |
Source
Source(1):